Elkins Christopher A, Nikaido Hiroshi
Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3206, USA.
J Bacteriol. 2002 Dec;184(23):6490-8. doi: 10.1128/JB.184.23.6490-6499.2002.
AcrAB-TolC is a constitutively expressed, tripartite efflux transporter complex that functions as the primary resistance mechanism to lipophilic drugs, dyes, detergents, and bile acids in Escherichia coli. TolC is an outer membrane channel, and AcrA is an elongated lipoprotein that is hypothesized to span the periplasm and coordinate efflux of such substrates by AcrB and TolC. AcrD is an efflux transporter of E. coli that provides resistance to aminoglycosides as well as to a limited range of amphiphilic agents, such as bile acids, novobiocin, and fusidic acid. AcrB and AcrD belong to the resistance nodulation division superfamily and share a similar topology, which includes a pair of large periplasmic loops containing more than 300 amino acid residues each. We used this knowledge to test several plasmid-encoded chimeric constructs of acrD and acrB for substrate specificity in a marR1 DeltaacrB DeltaacrD host. AcrD chimeras were constructed in which the large, periplasmic loops between transmembrane domains 1 and 2 and 7 and 8 were replaced with the corresponding loops of AcrB. Such constructs provided resistance to AcrB substrates at levels similar to native AcrB. Conversely, AcrB chimeras containing both loops of AcrD conferred resistance only to the typical substrates of AcrD. These results cannot be explained by simply assuming that AcrD, not hitherto known to interact with AcrA, acquired this ability by the introduction of the loop regions of AcrB, because (i) both AcrD and AcrA were found, in this study, to be required for the efflux of amphiphilic substrates, and (ii) chemical cross-linking in intact cells efficiently produced complexes between AcrD and AcrA. Since AcrD can already interact with AcrA, the alterations in substrate range accompanying the exchange of loop regions can only mean that substrate recognition (and presumably binding) is determined largely by the two periplasmic loops.
AcrAB-TolC是一种组成型表达的三方外排转运体复合物,它是大肠杆菌中对亲脂性药物、染料、去污剂和胆汁酸产生耐药性的主要机制。TolC是一种外膜通道,AcrA是一种细长的脂蛋白,据推测它跨越周质并协调AcrB和TolC对此类底物的外排。AcrD是大肠杆菌的一种外排转运体,它对氨基糖苷类药物以及有限范围的两亲性药物(如胆汁酸、新生霉素和夫西地酸)具有耐药性。AcrB和AcrD属于耐药结节化分化超家族,具有相似的拓扑结构,其中包括一对大的周质环,每个周质环含有300多个氨基酸残基。我们利用这一知识在marR1ΔacrBΔacrD宿主中测试了几种质粒编码的acrD和acrB嵌合构建体的底物特异性。构建了AcrD嵌合体,其中跨膜结构域1和2以及7和8之间的大周质环被AcrB的相应环取代。此类构建体对AcrB底物的耐药水平与天然AcrB相似。相反,含有AcrD两个环的AcrB嵌合体仅对AcrD的典型底物具有耐药性。这些结果不能简单地通过假设迄今未知与AcrA相互作用的AcrD通过引入AcrB的环区域而获得这种能力来解释,因为(i)在本研究中发现AcrD和AcrA都是两亲性底物外排所必需的,并且(ii)完整细胞中的化学交联有效地产生了AcrD和AcrA之间的复合物。由于AcrD已经可以与AcrA相互作用,因此伴随环区域交换的底物范围变化只能意味着底物识别(大概还有结合)在很大程度上由两个周质环决定。